The short version
Only one company currently supplies this market — there is no backup if it stumbles.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
AD Anti-Chafing
AD Anti-Chafing · LANOLIN 15.5 g/100g; PETROLATUM 53.4 g/100g · Ointment · Topical · WellSpring Pharmaceutical Corporation
NDC 65197-0408-15 · 1 TUBE in 1 BOX / 42.5 g in 1 TUBE · OTC MONOGRAPH DRUG · View full market →
Medicare Part D
Medicare Part D does not cover over-the-counter drugs — by law it pays only for products requiring a prescription.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- M016
- TE code
- —
- Approval date
- —
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of AD Anti-Chafing (Ointment)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| WellSpring Pharmaceutical Corporation | LANOLIN 15.5 g/100g; PETROLATUM 53.4 g/100g | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "AD Anti-Chafing — NDC 65197-0408-15," retrieved September 3, 2026, https://drugdashboards.com/drug/65197040815.
Free to cite with attribution — see how the data is put together.